These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 32845889)

  • 1. Systematic review and meta-analysis of the epidemiology of Lassa virus in humans, rodents and other mammals in sub-Saharan Africa.
    Kenmoe S; Tchatchouang S; Ebogo-Belobo JT; Ka'e AC; Mahamat G; Guiamdjo Simo RE; Bowo-Ngandji A; Demeni Emoh CP; Che E; Tchami Ngongang D; Amougou-Atsama M; Nzukui ND; Mbongue Mikangue CA; Mbaga DS; Kenfack S; Kingue Bebey SR; Amvongo Adjia N; Efietngab AN; Tazokong HR; Modiyinji AF; Kengne-Nde C; Sadeuh-Mba SA; Njouom R
    PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008589. PubMed ID: 32845889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geographic distribution and genetic characterization of Lassa virus in sub-Saharan Mali.
    Safronetz D; Sogoba N; Lopez JE; Maiga O; Dahlstrom E; Zivcec M; Feldmann F; Haddock E; Fischer RJ; Anderson JM; Munster VJ; Branco L; Garry R; Porcella SF; Schwan TG; Feldmann H
    PLoS Negl Trop Dis; 2013; 7(12):e2582. PubMed ID: 24340119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Prevalence of Lassa Fever Virus-Positive Rodents and Diversity of Infected Species Found during Human Lassa Fever Epidemics in Nigeria.
    Happi AN; Olumade TJ; Ogunsanya OA; Sijuwola AE; Ogunleye SC; Oguzie JU; Nwofoke C; Ugwu CA; Okoro SJ; Otuh PI; Ngele LN; Ojo OO; Adelabu A; Adeleye RF; Oyejide NE; Njaka CS; Heeney JL; Happi CT
    Microbiol Spectr; 2022 Aug; 10(4):e0036622. PubMed ID: 35913205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Households as hotspots of Lassa fever? Assessing the spatial distribution of Lassa virus-infected rodents in rural villages of Guinea.
    Mariën J; Lo Iacono G; Rieger T; Magassouba N; Günther S; Fichet-Calvet E
    Emerg Microbes Infect; 2020 Dec; 9(1):1055-1064. PubMed ID: 32459576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lassa virus in novel hosts: insights into the epidemiology of lassa virus infections in southern Nigeria.
    Happi AN; Ogunsanya OA; Ayinla AO; Sijuwola AE; Saibu FM; Akano K; Nwofoke C; Elias OT; Achonduh-Atijegbe O; Daodu RO; Adedokun OA; Adeyemo A; Ogundana KE; Lawal OZ; Parker E; Nosamiefan I; Okolie J; Parker ZF; McCauley MD; Eller LA; Lombardi K; Tiamiyu AB; Iroezindu M; Akinwale E; Njatou TLFA; Mebrahtu T; Broach E; Zuppe A; Prins P; Lay J; Amare M; Modjarrad K; Collins ND; Vasan S; Tucker C; Daye S; Happi CT
    Emerg Microbes Infect; 2024 Dec; 13(1):2294859. PubMed ID: 38088796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematics, Ecology, and Host Switching: Attributes Affecting Emergence of the Lassa Virus in Rodents across Western Africa.
    Olayemi A; Fichet-Calvet E
    Viruses; 2020 Mar; 12(3):. PubMed ID: 32183319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lassa virus diversity and feasibility for universal prophylactic vaccine.
    Lukashevich IS; Paessler S; de la Torre JC
    F1000Res; 2019; 8():. PubMed ID: 30774934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)-Study protocol.
    Penfold S; Adegnika AA; Asogun D; Ayodeji O; Azuogu BN; Fischer WA; Garry RF; Grant DS; Happi C; N'Faly M; Olayinka A; Samuels R; Sibley J; Wohl DA; Accrombessi M; Adetifa I; Annibaldis G; Camacho A; Dan-Nwafor C; Deha ARE; DeMarco J; Duraffour S; Goba A; Grais R; Günther S; Honvou ÉJJP; Ihekweazu C; Jacobsen C; Kanneh L; Momoh M; Ndiaye A; Nsaibirni R; Okogbenin S; Ochu C; Ogbaini E; Logbo ÉPMA; Sandi JD; Schieffelin JS; Verstraeten T; Vielle NJ; Yadouleton A; Yovo EK;
    PLoS One; 2023; 18(3):e0283643. PubMed ID: 36996258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of yellow fever virus in humans, arthropods, and non-human primates in sub-Saharan Africa: A systematic review and meta-analysis.
    Oyono MG; Kenmoe S; Abanda NN; Takuissu GR; Ebogo-Belobo JT; Kenfack-Momo R; Kengne-Nde C; Mbaga DS; Tchatchouang S; Kenfack-Zanguim J; Lontuo Fogang R; Zeuko'o Menkem E; Ndzie Ondigui JL; Kame-Ngasse GI; Magoudjou-Pekam JN; Bowo-Ngandji A; Nkie Esemu S; Ndip L
    PLoS Negl Trop Dis; 2022 Jul; 16(7):e0010610. PubMed ID: 35867659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inoculation route-dependent Lassa virus dissemination and shedding dynamics in the natural reservoir -
    Wozniak DM; Riesle-Sbarbaro SA; Kirchoff N; Hansen-Kant K; Wahlbrink A; Stern A; Lander A; Hartmann K; Krasemann S; Kurth A; Prescott J
    Emerg Microbes Infect; 2021 Dec; 10(1):2313-2325. PubMed ID: 34792436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The niche of One Health approaches in Lassa fever surveillance and control.
    Arruda LB; Haider N; Olayemi A; Simons D; Ehichioya D; Yinka-Ogunleye A; Ansumana R; Thomason MJ; Asogun D; Ihekweazu C; Fichet-Calvet E; Kock RA
    Ann Clin Microbiol Antimicrob; 2021 Apr; 20(1):29. PubMed ID: 33894784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence and risk factors for Lassa virus infection in South-West and North-Central Nigeria: a community-based cross-sectional study.
    Tiamiyu AB; Adegbite OA; Freides O; Frndak S; Mohammed SS; Broach E; Lombardi K; Anyebe V; Akiga R; Okeke NC; Feyisayo JE; Ugwuezumba O; Akinde C; Osuji A; Agu N; Analogbei T; Ekweremadu C; Bartolanzo D; Prins P; Fan Y; Emekaili D; Abah F; Chiwetelu V; Dike P; Isaiah E; Ayogu M; Ogunkelu E; Agbaim UC; Bukunmi A; Adamu Y; Mebrahtu T; Zuppe A; Johnston M; Modjarrad K; Meri H; Parker Z; Akinwale E; McCauley MD; Schluck G; King DB; Eller LA; Okeji N; Ayemoba OR; Collins ND; Iroezindu MO; Hakre S;
    BMC Infect Dis; 2024 Oct; 24(1):1118. PubMed ID: 39375602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population structure of Lassa Mammarenavirus in West Africa.
    Forni D; Sironi M
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32294960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lassa Virus Seroprevalence in Sibirilia Commune, Bougouni District, Southern Mali.
    Sogoba N; Rosenke K; Adjemian J; Diawara SI; Maiga O; Keita M; Konaté D; Keita AS; Sissoko I; Boisen M; Nelson D; Oottamasathien D; Millett M; Garry RF; Branco LM; Traoré SF; Doumbia S; Feldmann H; Safronetz D
    Emerg Infect Dis; 2016 Apr; 22(4):657-63. PubMed ID: 26981786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lassa fever - the road ahead.
    Garry RF
    Nat Rev Microbiol; 2023 Feb; 21(2):87-96. PubMed ID: 36097163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current research for a vaccine against Lassa hemorrhagic fever virus.
    Warner BM; Safronetz D; Stein DR
    Drug Des Devel Ther; 2018; 12():2519-2527. PubMed ID: 30147299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluctuation of abundance and Lassa virus prevalence in Mastomys natalensis in Guinea, West Africa.
    Fichet-Calvet E; Lecompte E; Koivogui L; Soropogui B; Doré A; Kourouma F; Sylla O; Daffis S; Koulémou K; Ter Meulen J
    Vector Borne Zoonotic Dis; 2007; 7(2):119-28. PubMed ID: 17627428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Routine and pulse vaccination for Lassa virus could reduce high levels of endemic disease: A mathematical modelling study.
    Davies J; Lokuge K; Glass K
    Vaccine; 2019 Jun; 37(26):3451-3456. PubMed ID: 31088745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatio-temporal spread and evolution of Lassa virus in West Africa.
    Wang X; Ye X; Li R; Zai X; Hu M; Wang S; Ren H; Jin Y; Xu J; Yue J
    BMC Infect Dis; 2024 Mar; 24(1):314. PubMed ID: 38486143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.